Reset Pharmaceuticals
New York, US · Founded 2020 · Delaware corporation
Biotech
Founders & leadership
JA
John AndreadisExecutive Officer, Director
JK
Jan-Anders KarlssonExecutive Officer, Director
PT
Philip TaubDirector
TS
Tim SchlidtDirector
Reported raises · per SEC filings
Form D private placements▶$11.1MraisedFeb 2022 · 26 investors · PharmaceuticalsRule 506(b)
Officers, directors & promoters on the filing
- John AndreadisExecutive Officer, Director
- Jan-Anders KarlssonExecutive Officer, Director
- Philip TaubDirector
- Tim SchlidtDirector
- Offering amount
- $12.7M
- Amount sold
- $11.1M
- Minimum investment
- $25K
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.